Showing results (181-190 of 213) with videos related to
Sort By:
Pageof 22
The European Respiratory Journal|August 2, 2005
A dynamic population model of disease progression in COPDM Hoogendoorn, M P M H Rutten-van Mölken, R T Hoogenveen, et al.Pharmacoeconomics|June 10, 2023
Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP RegistryXinyu Li, Rudolf Hoogenveen, Mohamed El Alili, et al.Plos Medicine|February 8, 2008
Lifetime medical costs of obesity: prevention no cure for increasing health expenditurePieter H M van Baal, Johan J Polder, G Ardine de Wit, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling MeetingMartine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.Diabetic Medicine : a Journal of the British Diabetic Association|May 27, 2015
Policy evaluation in diabetes prevention and treatment using a population-based macro simulation model: the MICADO modelA A W A van der Heijden, T L Feenstra, R T Hoogenveen, et al.Diabetologia|August 1, 2020
A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspectiveSajad Emamipour, Amber A W A van der Heijden, Giel Nijpels, et al.Journal of Diabetes Science and Technology|July 11, 2022
Personalizing the Use of a Intermittently Scanned Continuous Glucose Monitoring Device in Individuals With Type 1 Diabetes: A Cost-Effectiveness Perspective in the Netherlands (FLARE-NL 9)Sajad Emamipour, Peter R van Dijk, Henk J G Bilo, et al.Frontiers in Psychiatry|November 11, 2020
Effectiveness of the Boston University Approach to Psychiatric Rehabilitation in Improving Social Participation in People With Severe Mental Illnesses: A Randomized Controlled TrialSarita A Sanches, Wilma E Swildens, Barbara Schaefer, et al.The British Journal of Surgery|February 5, 2020
Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancerE R C Hagens, M L Feenstra, W J Eshuis, et al.Diabetes Care|May 5, 2023
Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven SubgroupsXinyu Li, Anoukh van Giessen, James Altunkaya, et al.Pageof 22